$CMRX
CHIMERIX INC Stock $cmrx

$cmrx Overview Financials Valuation SEC Filings Company Website

2018 Q2 Form 10-Q Financial Statement

#000111748018000023 Filed on May 07, 2018

Income Statement

Concept	2018 Q2	2018 Q1	2017 Q1
Revenue	$1.193M	$790.0K	$1.078M
YoY Change	76.74%	-26.72%	-12.21%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$6.650M	$6.740M	$6.600M
YoY Change	5.89%	2.12%	-4.62%
% of Gross Profit
Research & Development	$13.71M	$14.36M	$12.74M
YoY Change	17.84%	12.69%	-39.14%
% of Gross Profit
Depreciation & Amortization	$240.0K	$248.0K	$281.0K
YoY Change	-14.29%	-11.74%	5.24%
% of Gross Profit
Operating Expenses	$20.36M	$21.10M	$19.34M
YoY Change	13.63%	9.1%	-30.59%
Operating Profit	-$19.17M	-$20.31M	-$18.26M
YoY Change	11.16%	11.21%	-31.44%
Interest Expense	$630.0K	$620.0K	$510.0K
YoY Change	10.53%	21.57%	37.84%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$18.61M	-$19.83M	-$17.75M
YoY Change	11.57%	11.72%	-32.41%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$18.61M	-$19.83M	-$17.75M
YoY Change	11.59%	11.67%	-32.39%
Net Earnings / Revenue	-1560.18%	-2509.62%	-1646.94%
Basic Earnings Per Share
Diluted Earnings Per Share	-$389.2K	-$416.2K	-$381.1K
COMMON SHARES
Basic Shares Outstanding	47.75M shares	47.65M shares	46.56M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2018 Q2	2018 Q1	2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$174.8M	$160.4M	$161.7M
YoY Change	17.71%	-0.8%	-38.59%
Cash & Equivalents	$27.45M	$22.11M	$21.87M
Short-Term Investments	$147.3M	$138.3M	$139.8M
Other Short-Term Assets	$3.300M	$3.100M	$2.400M
YoY Change	6.45%	29.17%	-51.02%
Inventory
Prepaid Expenses
Receivables	$219.0K	$426.0K	$811.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$178.3M	$163.9M	$164.9M
YoY Change	17.56%	-0.59%	-38.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.502M	$1.688M	$2.567M
YoY Change	-34.87%	-34.24%	-14.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$21.10M	$49.20M	$104.9M
YoY Change	-79.63%	-53.1%	100.19%
Other Assets	$52.00K	$61.00K	$59.00K
YoY Change	1.96%	3.39%	-7.81%
Total Long-Term Assets	$22.67M	$50.97M	$107.5M
YoY Change	-78.61%	-52.59%	93.95%
TOTAL ASSETS
Total Short-Term Assets	$178.3M	$163.9M	$164.9M
Total Long-Term Assets	$22.67M	$50.97M	$107.5M
Total Assets	$201.0M	$214.9M	$272.4M
YoY Change	-22.0%	-21.11%	-15.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.426M	$1.892M	$2.813M
YoY Change	-11.37%	-32.74%	-21.16%
Accrued Expenses	$7.976M	$7.109M	$5.819M
YoY Change	29.5%	22.17%	-12.34%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$9.402M	$9.001M	$8.632M
YoY Change	21.04%	4.27%	-15.42%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$200.0K	$200.0K	$400.0K
YoY Change	0.0%	-50.0%	33.33%
Total Long-Term Liabilities	$200.0K	$200.0K	$400.0K
YoY Change	0.0%	-50.0%	33.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.402M	$9.001M	$8.632M
Total Long-Term Liabilities	$200.0K	$200.0K	$400.0K
Total Liabilities	$9.587M	$9.207M	$9.033M
YoY Change	19.63%	1.93%	-14.27%
SHAREHOLDERS EQUITY
Retained Earnings	-$525.2M	-$506.6M	-$433.6M
YoY Change	16.66%	16.85%	18.56%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$191.4M	$205.7M	$263.4M
YoY Change
Total Liabilities & Shareholders Equity	$201.0M	$214.9M	$272.4M
YoY Change	-22.0%	-21.11%	-15.99%

Cashflow Statement

Concept	2018 Q2	2018 Q1	2017 Q1
OPERATING ACTIVITIES
Net Income	-$18.61M	-$19.83M	-$17.75M
YoY Change	11.59%	11.67%	-32.39%
Depreciation, Depletion And Amortization	$240.0K	$248.0K	$281.0K
YoY Change	-14.29%	-11.74%	5.24%
Cash From Operating Activities	-$14.04M	-$18.51M	-$13.62M
YoY Change	7.92%	35.89%	-52.43%
INVESTING ACTIVITIES
Capital Expenditures	-$60.00K	$42.00K	$5.000K
YoY Change	500.0%	740.0%	-97.84%
Acquisitions
YoY Change
Other Investing Activities	$19.37M	$21.98M	-$16.36M
YoY Change	29.65%	-234.35%	-145.96%
Cash From Investing Activities	$19.32M	$21.94M	-$16.37M
YoY Change	29.4%	-234.02%	-146.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	50.00K	$138.0K	$395.0K
YoY Change	-50.0%	-65.06%	137.95%
NET CHANGE
Cash From Operating Activities	-14.04M	-$18.51M	-$13.62M
Cash From Investing Activities	19.32M	$21.94M	-$16.37M
Cash From Financing Activities	50.00K	$138.0K	$395.0K
Net Change In Cash	5.330M	$3.564M	-$29.60M
YoY Change	163.86%	-112.04%	-529.07%
FREE CASH FLOW
Cash From Operating Activities	-$14.04M	-$18.51M	-$13.62M
Capital Expenditures	-$60.00K	$42.00K	$5.000K
Free Cash Flow	-$13.98M	-$18.55M	-$13.63M
YoY Change	7.54%	36.15%	-52.79%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q4	cmrx	Accrued Development Liabilities AccruedDevelopmentLiabilities	3384000	USD
CY2018Q1	cmrx	Accrued Development Liabilities AccruedDevelopmentLiabilities	4084000	USD
CY2017Q4	cmrx	Accrued Indemnification Claim AccruedIndemnificationClaim	1000000	USD
CY2018Q1	cmrx	Accrued Indemnification Claim AccruedIndemnificationClaim	0	USD
CY2018Q1	cmrx	Available For Sale Securities Debt Securities And Equity Securities Fvni AvailableForSaleSecuritiesDebtSecuritiesAndEquitySecuritiesFVNI	187560000	USD
CY2018Q1	cmrx	Availableforsale Securities Debt Maturities Year Two Fair Value AvailableforsaleSecuritiesDebtMaturitiesYearTwoFairValue	49225000	USD
CY2018Q1	cmrx	Equity Securities Fvni EquitySecuritiesFVNI	252000	USD
CY2017Q1	cmrx	Equity Securities Fvni Gain Loss EquitySecuritiesFVNIGainLoss	0	USD
CY2018Q1	cmrx	Equity Securities Fvni Gain Loss EquitySecuritiesFVNIGainLoss	-134000	USD
CY2018Q1	dei	Amendment Flag AmendmentFlag	false
CY2018Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2018Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018Q1	dei	Document Period End Date DocumentPeriodEndDate	2018-03-31
CY2018Q1	dei	Document Type DocumentType	10-Q
CY2018Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001117480
CY2018Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	47753300	shares
CY2018Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2018Q1	dei	Entity Registrant Name EntityRegistrantName	CHIMERIX INC
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3812000	USD
CY2018Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1892000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1682000	USD
CY2018Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	426000	USD
CY2017Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-72000	USD
CY2018Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	73000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9384000	USD
CY2018Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7109000	USD
CY2017Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	3678000	USD
CY2018Q1	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	1911000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-963000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1066000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	709514000	USD
CY2018Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	713323000	USD
CY2017Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4028000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3391000	USD
CY2017Q4	us-gaap	Assets Assets	235230000	USD
CY2018Q1	us-gaap	Assets Assets	214898000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	156533000	USD
CY2018Q1	us-gaap	Assets Current AssetsCurrent	163924000	USD
CY2018Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2018Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1064000	USD
CY2018Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	188372000	USD
CY2017Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	209317000	USD
CY2017Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2017Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	963000	USD
CY2017Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	210280000	USD
CY2017Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	92000	USD
CY2018Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	266000	USD
CY2017Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	963000	USD
CY2018Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	1064000	USD
CY2017Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	209317000	USD
CY2018Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	187308000	USD
CY2017Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	871000	USD
CY2018Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	798000	USD
CY2017Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	170390000	USD
CY2018Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	103949000	USD
CY2017Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	38927000	USD
CY2018Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	83359000	USD
CY2017Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	132972000	USD
CY2018Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	138335000	USD
CY2018Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	138083000	USD
CY2018Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	187308000	USD
CY2017Q4	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	39	security
CY2018Q1	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	25	security
CY2017Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	76731000	USD
CY2018Q1	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	49225000	USD
CY2017Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	46	security
CY2018Q1	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	43	security
CY2017Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	7	security
CY2018Q1	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	18	security
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51463000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21866000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18548000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22112000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-29597000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	3564000	USD
CY2018Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	47505532	shares
CY2018Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	47753300	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47505532	shares
CY2018Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47753300	shares
CY2017Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	47000	USD
CY2018Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	48000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17423000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19929000	USD
CY2017Q1	us-gaap	Contracts Revenue ContractsRevenue	1078000	USD
CY2018Q1	us-gaap	Contracts Revenue ContractsRevenue	790000	USD
CY2017Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	224000	USD
CY2018Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	206000	USD
CY2017Q1	us-gaap	Depreciation Depreciation	281000	USD
CY2018Q1	us-gaap	Depreciation Depreciation	248000	USD
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.38
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.42
CY2017Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6596000	USD
CY2018Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6738000	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1440000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3925000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-787000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1256000	USD
CY2017Q1	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-47000	USD
CY2018Q1	us-gaap	Increase Decrease In Deferred Liabilities IncreaseDecreaseInDeferredLiabilities	-11000	USD
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-450000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-294000	USD
CY2017Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	506000	USD
CY2018Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	615000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	13420000	USD
CY2018Q1	us-gaap	Liabilities Liabilities	9207000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	235230000	USD
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	214898000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13196000	USD
CY2018Q1	us-gaap	Liabilities Current LiabilitiesCurrent	9001000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	395000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	138000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16369000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	21938000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13623000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18512000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-17754000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-19826000	USD
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	19338000	USD
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	21097000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-18260000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-20307000	USD
CY2017Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	200000	USD
CY2018Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	200000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1322000	USD
CY2018Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1114000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	72000	USD
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	61000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	331000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-103000	USD
CY2017Q1	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2018Q1	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
CY2017Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2018Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	280000	USD
CY2017Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	87509000	USD
CY2018Q1	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	6031000	USD
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5000	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	42000	USD
CY2017Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	USD
CY2018Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	1989000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2018Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2018Q1	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3331000	USD
CY2018Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3051000	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	386000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	358000	USD
CY2017Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	71145000	USD
CY2018Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	20500000	USD
CY2017Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	0	USD
CY2018Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	9500000	USD
CY2017Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	9000	USD
CY2018Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	60000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1894000	USD
CY2018Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1688000	USD
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12742000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14359000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-486788000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-506614000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4028000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3391000	USD
CY2018Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	146800	shares
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	221810000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	205691000	USD
CY2018Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2017Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	46573394	shares
CY2018Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	47637907	shares

Files In Submission

Name	View Source	Status
0001117480-18-000023-index-headers.html	Edgar Link	pending
0001117480-18-000023-index.html	Edgar Link	pending
0001117480-18-000023.txt	Edgar Link	pending
0001117480-18-000023-xbrl.zip	Edgar Link	pending
a20180331cmrx10-qdocument.htm	Edgar Link	pending
a20180331cmrxex-101.htm	Edgar Link	pending
a20180331cmrxex-103.htm	Edgar Link	pending
a20180331cmrxex-311.htm	Edgar Link	pending
a20180331cmrxex-312.htm	Edgar Link	pending
a20180331cmrxex-321.htm	Edgar Link	pending
a20180331cmrxex-322.htm	Edgar Link	pending
cmrx-20180331.xml	Edgar Link	completed
cmrx-20180331.xsd	Edgar Link	pending
cmrx-20180331_cal.xml	Edgar Link	unprocessable
cmrx-20180331_def.xml	Edgar Link	unprocessable
cmrx-20180331_lab.xml	Edgar Link	unprocessable
cmrx-20180331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CMRX
CHIMERIX INC Stock $cmrx

2018 Q2 Form 10-Q Financial Statement

#000111748018000023 Filed on May 07, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMRX CHIMERIX INC Stock $cmrx

2018 Q2 Form 10-Q Financial Statement

#000111748018000023 Filed on May 07, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CMRX
CHIMERIX INC Stock $cmrx